Helus Pharma Inc. (HELP) stock
HELPNasdaqPharmaceutical PreparationsFiscal year ends March 31
Số liệu tài chính tới năm tài chính 2026, năm kết thúc ngày Mar 31, 2026Last filing: 40-F on Jun 29, 2026Score 0/30
$7.20−0.47 (-6.13%)
Close on Nov 17, 2026Market cap $371.75MP/E –Yield –
Helus Pharma price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Helus Pharma's price to sales ratio was 99.5× on May 31, 2022.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2022 | May 31, 2022 | 99.5× | −78.0 |
| 2021 | Dec 31, 2021 | 177.5× | – |
See a number that looks wrong?